GG
MRNA icon

Golden Green’s Moderna MRNA Stock Holding History

Golden Green’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-25,722
Closed -$9.9M – 146
2021
Q3 		$9.9M Sell
25,722
-3,834
-13% -$1.41M 7.72% 2
2021
Q2 		$6.95M Sell
29,556
-1,307
-4% -$234K 5.32% 2
2021
Q1 		$4.04M Sell
30,863
-2,256
-7% -$327K 3.49% 2
2020
Q4 		$3.46M Buy
+33,119
New +$3.35M 3.22% 4

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Golden Green's MRNA Position: Q4 2021 in Review

Golden Green sold out of Moderna (MRNA) in Q4 2021, closing a stake of 25,722 shares — an estimated $9.9M sold.

Golden Green first reported a position in MRNA in Q4 2020 and held it in 4 quarters. The position peaked at $9.9M in Q3 2021. 1,109 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.

  • Golden Green reported no remaining Moderna position as of Q4 2021 after selling out during the quarter.
  • Golden Green sold 25,722 Moderna shares in Q4 2021, an estimated $9.9M.
  • Golden Green first reported a position in Moderna in Q4 2020 and held it in 4 quarters.
  • Golden Green's Moderna position peaked at $9.9M in Q3 2021.
  • 1,109 funds tracked by Wall St. Rank held Moderna as of Q4 2021.

Based on Golden Green's 13F filing for Q4 2021, filed 21 Jan 2022.